Clinical Trial Update: The Prospective Study of Standard Treatment of Graves Disease Iodine 131 and Prevention of Adverse Reactions [Phase 3]

View source ↗

Summary

This entry covers an ongoing Phase 3 prospective trial of standard iodine-131 treatment for Graves' disease and prevention of adverse reactions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Exophthalmos
• Graves Disease
• Hypothyroidism

Drugs mentioned

• Iodine-131 (Iodine-131)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hypothyroidism, Exophthalmos | Phase 3 | Status: UNKNOWN